Edition:
United States

Tekla Life Sciences Investors (HQL.N)

HQL.N on New York Stock Exchange

21.33USD
22 Sep 2017
Change (% chg)

$-0.04 (-0.19%)
Prev Close
$21.37
Open
$21.35
Day's High
$21.37
Day's Low
$21.29
Volume
18,775
Avg. Vol
14,907
52-wk High
$22.23
52-wk Low
$15.86

Chart for

About

Tekla Life Sciences Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in the United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed... (more)
No analyst recommendations are available for .

Overall

Beta: 1.74
Market Cap(Mil.): $451.56
Shares Outstanding(Mil.): 21.17
Dividend: 0.42
Yield (%): 7.45

Financials

  Industry Sector
P/E (TTM): -- 5.99 16.08
EPS (TTM): -- -- --
ROI: -- 2.30 14.60
ROE: -- 2.96 14.03

Earnings vs. Estimates

No consensus analysis data available.